The Increasing Weight of Crohnʼs Disease Subjects in Clinical Trials

Nucleotide Oligomerization Domains 1 and 2: Regulation of Expression and Function in Preadipocytes

(2014) T. Stroh et al.   JOURNAL OF IMMUNOLOGY

Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial

(2012) Paul Rutgeerts et al.   GASTROENTEROLOGY

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

(2012) Wolfgang Hueber et al.   GUT

Ratio of Visceral to Subcutaneous Fat Area Is a Biomarker of Complicated Crohn's Disease

(2011) Bara Erhayiem et al.   Clinical Gastroenterology and Hepatology

Is Obesity a Risk Factor for Crohn’s Disease?

(2011) Michael A. Mendall et al.   DIGESTIVE DISEASES AND SCIENCES

Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease

(2011) Laurent Peyrin-Biroulet et al.   GUT

Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohnʼs disease: Results from CARE

(2011) Robert Löfberg et al.   INFLAMMATORY BOWEL DISEASES

Intestinal Permeability Is Associated With Visceral Adiposity in Healthy Women

(2011) Anders Gummesson et al.   Obesity

Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial

(2010) W. Reinisch et al.   GUT

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

(2010) Andre Franke et al.   NATURE GENETICS

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

(2010) Jean Frédéric Colombel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Breastfeeding and genetic factors in the etiology of inflammatory bowel disease in children

(2009) Theresa A Mikhailov et al.   WORLD JOURNAL OF GASTROENTEROLOGY

A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease

(2008) William J. Sandborn et al.   GASTROENTEROLOGY

Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases

(2008) C. N Bernstein et al.   GUT

Prevalence and clinical significance of sonographic evidence of mesenteric fat alterations in Crohnʼs disease

(2008) Giovanni Maconi et al.   INFLAMMATORY BOWEL DISEASES

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

(2008) Geert D'Haens et al.   LANCET